Articles On Avita Medical (ASX:AVH)

Title Source Codes Date
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

Stockhead AVH 2 years ago
Avita Medical (ASX:AVH) share price sinks to 52-week low despite ‘pivotal’ trial update

The AVITA Medical Inc (ASX: AVH) share price has dropped to a 52-week low today despite news that the medical producer has entered its RECELL System product into a trial. Today’s slide comes off the back of a 2.78% fall yesterday after th...

Motley Fool AVH 2 years ago
Down 22% in a month: Why is the Avita Medical (ASX:AVH) share price sliding again today?

Shares in regenerative medicine group Avita Medical Inc (ASX: AVH) are in the red today, down 2.78% to $3.50. This means the Avita share price is now down 22.08% over the past month. Today’s falling share price comes amid an announcement...

Motley Fool AVH 2 years ago
Trading Places: Which large cap resources stocks proved irresistible to substantial shareholders?

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

Stockhead AVH 2 years ago
Life360 is up 182% since its IPO – which other US tech stocks are having success on the ASX?

It’s now been two-and-a-half years since US tech stock Life360 (ASX:360) listed on the ASX at $4.79 a share and it now sits at $13.51. The company’s flagship product is a smartphone app that provides information such as where families membe...

Stockhead AVH 2 years ago
Why has the Avita Medical (ASX:AVH) share price just hit a 2-year low?

It was a disappointing day for the Avita Medical Inc (ASX: AVH) share price as it hit a new 2-year low. The regenerative medicine company has failed to regain momentum since the beginning of its fall from grace during the COVID-19 crash....

Motley Fool AVH 2 years ago
Closing Bell: ASX edges lower, but hydrogen stocks rip higher

The ASX closed down again today in spite of resources and tech gaining over 1%. The ASX 200 fell 0.24%, closing at 7,434 points. Despite the gains in resources and tech most other sectors fell with financials, property and energy retreating...

Stockhead AVH 2 years ago
Why Actinogen, AVITA, Inghams, and NAB shares are falling

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has dropped back into the red. At the time of writing, the benchmark index is down 0.15% to 7,442.1 points. Four ASX shares that are falling more than most today are listed below. He...

Motley Fool AVH 2 years ago
Avita Medical (ASX:AVH) share price sinks 11% on Q1 earnings

The Avita Medical Inc (ASX: AVH) share price is sliding well into the red in afternoon trading and is now down 10.98% at $4.54. It comes following the release of the company’s earnings report for the three months ended 30 September 2021....

Motley Fool AVH 2 years ago
AVITA Medical (ASX:AVH) rakes in $7m during Sept. quarter

AVITA Medical (AVH) raked in $7 million in revenue during the first quarter, representing a 39 per cent increase year-on-year The healthcare stock released its quarterly results on Tuesday, revealing its gross profit margin increased from...

themarketherald.com.au AVH 2 years ago
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval

The ASX 200 Health Index (XHJ) is up by 0.57% at the time of writing, compared to the broader index which is up by 0.03%. The US FDA has cleared Pharmaxis (ASX:PXS)’s Investigational New Drug application (IND) for a trial of its lead drug,...

Stockhead AVH 2 years ago
Brokers name 3 ASX shares to buy today

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these...

Motley Fool AVH 2 years ago
The Avita Medical (ASX:AVH) share price just leapt 16% because of this

Today was a great day on the ASX for the Avita Medical Inc (ASX: AVH) share price. The medical technology company’s stock was boosted by news that the US authority Centers for Medicare and Medicaid Services has approved Avita’s application...

Motley Fool AVH 2 years ago
Closing Bell: $20.3bn was raised on ASX in October, up 166pc year-on-year

The ASX rose 0.48% today to reach its highest point in the week. While energy lost 2% most other sectors were in the green with tech and financials gaining over 1%. Today’s gains came despite the Federal Reserve unveiling a tapering of stim...

Stockhead AVH 2 years ago
Why this medical tech ASX share could rocket today

The AVITA Medical Inc (ASX: AVH) share price will be keenly watched when the ASX opens on Thursday after some big news overnight pushed its US shares up 7%. The company provides regenerative medical technology, with its ReCell spray-on ski...

Motley Fool AVH 2 years ago
Advanced Human Imaging (ASX:AHI) NASDAQ listing edges closer

ASX-listed mobile health (mHealth) company Advanced Human Imaging (AHI) is moving forward with its planned dual-listing on the NASDAQ exchange Listing on the NASDAQ will place Advanced Human Imaging on one of the highest-quality and highes...

themarketherald.com.au AVH 2 years ago
AVITA Medical (ASX:AVH) share price up 7% following FY21 earnings

The AVITA Medical Inc (ASX: AVH) share price is climbing higher this morning following the release of the company’s financial year 2021 (FY21) earnings. at the time of writing, the AVITA share price is up 7.13%, trading at $5.335. AVITA Me...

Motley Fool AVH 2 years ago
Here’s why AVITA Medical, Pharmaxis and Telix shares are trending today

Highlights AVITA Medical disclosed that the US Food and Drug Administration (FDA) has authorised its request to amend the RECELL® System pivotal trial. Pharmaxis has granted Aptar Pharma an exclusive 12-month option for developing and...

Kalkine Media AVH 2 years ago
Avita Medical (ASX:AVH) share price jumps on FDA approval

The Avita Medical Inc (ASX: AVH) share price is in the green in early afternoon trade. Avita shares are on the move after the company gained regulatory momentum overnight. Let’s discuss further. A quick refresher on Avita Medical Avita...

Motley Fool AVH 2 years ago
Avita Medical receives FDA green light for US trial of potential vitiligo treatment

Melbourne-based medtech company Avita Medical (ASX: AVH) has received US Food and Drug Administration (FDA) approval to amend its clinical trial for the treatment of vitiligo patients, giving hope to the millions that suffer from the rare s...

businessnewsaustralia.com AVH 2 years ago
Market highlights and 5 ASX small caps to watch on Tuesday

Global markets stay cool US stocks edged higher overnight to post their fifth straight day of gains, as attention centred around geo-political concerns following the US withdrawal from Afghanistan. The Dow Jones rose by 0.31%, and the S&am...

Stockhead AVH 2 years ago
Short and Caught: It appears investors are responding to takeover bids… by shorting the targets’ rivals

In Short & Caught, Stockhead recaps the ASX stocks that are the most shorted right now.   How does shorting work? Shorting works by selling stocks you do not actually own in the hope of buying them back at a lower price. Investors are i...

Stockhead AVH 2 years ago
5 ASX shares to hold for 5 years

Buy ASX shares for the long term, we’re always told. Don’t try to time the market. But the irony is the same experts that espouse this to retail investors don’t, or can’t, follow it themselves. That’s because fund managers are judged by po...

Motley Fool AVH 2 years ago
3 small cap ASX shares to watch

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps. Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need t...

Motley Fool AVH 2 years ago
2 ASX shares to hold onto for the next 5 years

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, The Montgomery Fund portfolio manager Joseph Kim reveals a pair of ASX shares that he’d be intrig...

Motley Fool AVH 2 years ago
Best and worst performing ASX sectors of financial year 2021

Whether you take a contrarian view to investing or like to hop on what’s hot, it’s interesting to see which ASX sectors have fared the best in the past year. Perhaps you want to put some money into the sectors that haven’t gone so well, th...

Motley Fool AVH 2 years ago
Hold your nerve on this battered ASX share: expert

One much-hyped ASX share has given little joy to investors over the last 12 months. But The Montgomery Fund portfolio manager Joseph Kim has told holders of the healthcare stock to be patient, as the numbers still look pretty good. Regener...

Motley Fool AVH 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Wednesday

Wall Street takes record highs even higher All three US benchmarks rose overnight, as American consumer confidence for April rose the highest since the pandemic began and US house prices jumping the most in three decades. The Dow Jones and...

Stockhead AVH 2 years ago
Some encouraging updates from Avita Medical

If you are a longer-term shareholder of Avita Medical (ASX:AVH), it is likely you would have experienced a rather disappointing journey over the past 12 months. COVID-19 and lockdowns in the US have stymied the RECELL roll-out just as it wa...

Montgomery AVH 2 years ago
The surge and plunge in ASX biotech shows what the FDA giveth, the FDA taketh away

Over the past month, a number of US FDA approvals have moved the share prices of global pharma stocks, including those traded here on the ASX. The biggest FDA announcement during the month came out of US-based Biogen, which received a contr...

Stockhead AVH 2 years ago
Why analysts rate these small cap ASX shares as buys

While small cap ASX share carry more risk than their larger rivals, the potential returns on offer makes it worth considering including one or two in a balanced portfolio if your risk profile allows. But which small cap shares should you b...

Motley Fool AVH 2 years ago
The Week that Was – June 14-18, 2021

ShareCafeThe Week that Was – June 14-18, 2021 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so, h...

ShareCafe AVH 2 years ago
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week As we appro...

Stockhead AVH 2 years ago
ASX 200 morning report – AVH, SSG & IAG shares in focus

The S&P/ASX 200 (ASX: XJO) finished at another record, adding 0.1% on Wednesday despite weakening throughout the day. Most sectors finished higher, led by the energy sector, up 1.5%, with the materials and IT down 1.6% and 0.4%, respect...

Rask Media AVH 2 years ago
Avita Medical Gives Shareholders a Lift

ShareCafeAvita Medical Gives Shareholders a Lift Investors loved yesterday’s June quarter update from dual-listed skin repair biotech Avita Medical . The company raised its quarterly guidance due to the strength of orders for its flagship t...

ShareCafe AVH 2 years ago
ASX-listed stocks on investors' watchlist!

Summary Commonwealth Bank (ASX:CBA) sets new high, adds nearly A$7 billion in value over 3 weeks Orthocell (ASX:OCC) gets patents for suture-less repair of soft tissue AF Legal Group (ASX:AFL) completes Watts McCray acquisition...

Kalkine Media AVH 2 years ago
ASX 200 rises again, Avita jumps, Shaver Shop sinks

The S&P/ASX 200 Index (ASX: XJO) rose 0.1% to 7,386 points. Here are some of the highlights from the ASX today: AVITA Medical Inc (ASX: AVH) The Avita share price went up over 12% in reaction to an update about its FY21 fourth quarte...

Motley Fool AVH 2 years ago
Last Orders: ASX teeters on the edge of 7,400

The ASX climbed briefly past 7,400 points in intra-day trade but ultimately closed just short of the milestone at 7,.368, which was 0.09 per cent higher than yesterday. However, the ASX Emerging Companies Index fell by over 1 per cent for t...

Stockhead AVH 2 years ago
ASX 200 today: What to expect ahead of Fed’s statement

Summary The ASX 200 traded higher in the opening trade even as the US shares ended lower overnight. By 10:30 AM (AEST), the benchmark was trading at 7,391.50, up 0.16%. The US investors awaited the Federal Reserve’s monetary policy st...

Kalkine Media AVH 2 years ago
Q4 upgrade: Why the AVITA (ASX:AVH) share price is soaring

The AVITA Medical Inc (ASX: AVH) share price is soaring today, up 9%, after upgrading its FY21 fourth quarter expectations. AVITA is a regenerative medicine company that is developing and commercialising a technology platform that enables p...

Rask Media AVH 2 years ago
Why the AVITA (ASX:AVH) share price is jumping 8% today

The AVITA Medical Inc (ASX: AVH) share price is on the move on Wednesday. At the time of writing, the regenerative medicine company’s shares are up 8% to $5.40. Why is the AVITA share price jumping? Investors have been buying the company’s...

Motley Fool AVH 2 years ago
Market highlights and 5 ASX small caps to watch on Wednesday

Wall Street nervous as Fed goes into a two-day policy meeting All major indices in the US fell on Tuesday, ahead of a key policy announcement from the US central bank this Thursday (US time). The Dow Jones fell by 0.27%, S&P 500 by 0.20...

Stockhead AVH 2 years ago
Argenica Therapeutics (ASX:AGN) shares surge ~30% on Day 1 on the ASX

Summary Neuroprotective drug developer Argenica Therapeutics commenced trading on the ASX after a well-supported AU$7 million capital raising. The Company disclosed that the ASX listing would allow it to develop its novel neuroprotecti...

Kalkine Media AVH 2 years ago
Last Orders: ASX a whisker from closing the week at all time high

The ASX ended the week on a high note, finishing up 0.13 per cent with most sectors in positive territory. The index touched a record high of 7,334 today but failed to keep the momentum and eventually closed at 7,312. For the week, the inde...

Stockhead AVH 2 years ago
Avita Medical's burns treatment rejuvenated by FDA use extension

Avita Medical Inc. (ASX: AVH) has received a big shot in the arm following an extension of US Food and Drug Administration approvals for the company's treatment of acute burns wounds. The medtech company, which is also listed in the US (N...

businessnewsaustralia.com AVH 2 years ago
Why Afterpay, Altium, AVITA, & Domino’s shares are pushing higher

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to finish the week on a positive note. In afternoon trade, the benchmark index is up 0.2% to 7,315.8 points. Four ASX shares that are climbing more than most today are listed below. Her...

Motley Fool AVH 2 years ago
Why the Avita Medical (ASX:AVH) share price is soaring 14%

The Avita Medical Inc (ASX: AVH) share price is flying high on Friday. At the time of writing, shares in the medical technology business are swapping hands for $5.11 – up 13.56%. This comes after the company announced it had received appro...

Motley Fool AVH 2 years ago
FDA gives green light to Avita’s ‘spray-on’ burns treatment for children, shares gain

Burns treatment company Avita Medical (ASX:AVH) rose this morning after gaining further regulatory approval from the FDA. The company has a rapid cell harvesting device called RECELL which works as a ‘spray-on’ and allows patients to be tre...

Stockhead AVH 2 years ago
Why the AVITA (ASX:AVH) share price is booming

The AVITA Medical Inc (ASX: AVH) share price is up more than 14% after getting some positive news from the US FDA. AVITA is a regenerative medicine business that is developing and commercialising a “technology platform” that enables point-o...

Rask Media AVH 2 years ago
10 at 10: These ASX stocks are performing well this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead AVH 2 years ago